SensDx is a biotechnology company that develops new diagnostic technology
This product was launched in Poland in the autumn of 2019, and is already used at 100 doctors' offices and hospitals in the country.
The first internal evaluation of the SARS-CoV-2 test was performed on 100 positive and 500 negative samples with 92% sensitivity and 98.5% specificity.
Products under development
It is continuously researched and developed with the expansion of the product portfolio. Here are some products we have under development.